A new tumor marker that’s associated with many kinds of cancers, including one-third of breast and colon cancers, has been identified by Boston University School of Medicine researchers.They identified this new tumor marker (absence of SMAD8) using a new university-developed procedure called Targeted Expressed Gene Display (TEGD), which can identify related members of a large family of genes, their variants and their patterns of expression.
